Secondo le stime degli analisti, un dazio del 15% sui farmaci europei potrebbe costare allindustria tra i 13 e i 19 miliardi di dollari lanno
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Yes, Semaglutide has been on the market since 2005 and has undergone rigorous clinical trials, such as this 2022 efficacy and safety study, and is safe for weight loss when administered under the guidance of a knowledgeable healthcare provider
Understanding how to identify when semaglutide is causing bloating helps you manage it better and decide when its necessary to seek help from a healthcare provider
By managing blood glucose levels effectively, the medication aims to reduce the risk of major complications, such as heart disease